[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Irene Becklund, an officer of Hims & Hers Health, Inc. (HIMS), reported a sale of Class A common stock on 09/17/2025. The Form 4 shows she disposed of 8,410 shares at a price of $50.50 per share under transaction code S(1). After the sale, she beneficially owned 1,418 shares. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted August 7, 2024. The Form 4 was signed by Kimberly Mather as attorney-in-fact for Irene Becklund on 09/19/2025.

Positive

• Sale executed under a Rule 10b5-1 trading plan, indicating a prearranged disposal mechanism
• Form 4 includes necessary details (transaction date, amount, price, post-transaction holdings) and a signed submission

Negative

• Significant reduction in reported Class A holdings (8,410 shares sold, leaving 1,418 shares)
• No information provided on total beneficial ownership across other classes or indirect holdings

Insights

Financial Analyst

TL;DR: Officer sale of 8,410 HIMS shares at $50.50 under a 10b5-1 plan; remaining stake is 1,418 shares.

The transaction is a straightforward disposition reported on Form 4. The use of a Rule 10b5-1 plan indicates the sale was prearranged and not necessarily based on material nonpublic information. The size of the sale relative to the post-transaction holding (8,410 sold vs. 1,418 retained) materially reduces the reporting person's direct stake, which investors may note when assessing insider alignment, though the filing does not provide information on overall beneficial ownership beyond the Class A shares reported here.

Corporate Governance Expert

TL;DR: Compliance appears proper—sale executed under a pre-established 10b5-1 plan and reported on Form 4.

The filing includes the required disclosure elements: reporting person identity and address, relationship to issuer (officer/PAO), transaction date, number of shares disposed, price per share, and post-transaction ownership. Signature is provided by an attorney-in-fact. The document contains no disclosures of derivative transactions or other atypical arrangements. From a governance perspective, timely reporting and explicit mention of the 10b5-1 plan support procedural compliance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Becklund Irene

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PAO

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/17/2025		S(1)		8,410	D	$50.5	1,418	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 7, 2024 by the Reporting Person.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Irene Becklund	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Irene Becklund report in the Form 4 for HIMS?

She reported selling 8,410 shares of Class A common stock at $50.50 per share on 09/17/2025 and retaining 1,418 shares.

Was the sale executed under a Rule 10b5-1 plan?

Yes. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on August 7, 2024.

Who signed the Form 4 filing for Irene Becklund?

The form was signed by Kimberly Mather, Attorney-in-Fact for Irene Becklund, on 09/19/2025.

What is Irene Becklund's relationship to Hims & Hers?

The Form 4 indicates she is an officer and lists 'PAO' in the relationship section.

How many Class A shares did Becklund own after the reported transaction?

1,418 shares of Class A common stock were beneficially owned following the reported sale.